血流导向密网支架AUCURA™

Search documents
赛诺医疗(688108):业绩符合预期,期待颅内自膨载药支架国内获批
Soochow Securities· 2025-08-24 14:34
证券研究报告·公司点评报告·医疗器械 买入(维持) | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入(百万元) | 343.26 | 458.74 | 573.42 | 745.45 | 969.09 | | 同比(%) | 77.99 | 33.64 | 25.00 | 30.00 | 30.00 | | 归母净利润(百万元) | (39.63) | 1.50 | 31.41 | 58.18 | 79.90 | | 同比(%) | 75.59 | 103.78 | 1,997.13 | 85.21 | 37.34 | | EPS-最新摊薄(元/股) | (0.10) | 0.00 | 0.08 | 0.14 | 0.19 | | P/E(现价&最新摊薄) | (343.29) | 9,083.21 | 433.13 | 233.86 | 170.27 | [Table_Tag] [Table_Summary] 投资要点 ◼ 颅内自膨载药支架 ...